retatrutide clinical trials safety efficacy Retatrutide, an experimental weight-loss drug, has not been approved by Mazdutide vs retatrutide: dual agonist

Joseph Bernstein is a Times reporter who writes feature stories for the Styles section

Nobody in the beginning believed that it was possible to create an obesity treatment with this kind of drug

2012 [cited 2019 Dec 20];209(209):30935

It helps your body adjust to the medication and reduces the likelihood of gastrointestinal side effects such as nausea

Make sure your choice offers robust insurance and prior authorization help, as Klinic does, removing hurdles many clinics leave patients to face on their own

Whether practicing as a physician, nurse practitioner, physician associate, or registered dietitian, healthcare professionals need evidence-based, practical strategies to safely optimize GLP-1 therapy